Literature DB >> 29622466

Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.

Yang Liu1, Nilay S Sethi1, Toshinori Hinoue2, Barbara G Schneider3, Andrew D Cherniack1, Francisco Sanchez-Vega4, Jose A Seoane5, Farshad Farshidfar6, Reanne Bowlby7, Mirazul Islam1, Jaegil Kim8, Walid Chatila9, Rehan Akbani10, Rupa S Kanchi10, Charles S Rabkin11, Joseph E Willis12, Kenneth K Wang13, Shannon J McCall14, Lopa Mishra15, Akinyemi I Ojesina16, Susan Bullman17, Chandra Sekhar Pedamallu17, Alexander J Lazar18, Ryo Sakai19, Vésteinn Thorsson20, Adam J Bass21, Peter W Laird22.   

Abstract

We analyzed 921 adenocarcinomas of the esophagus, stomach, colon, and rectum to examine shared and distinguishing molecular characteristics of gastrointestinal tract adenocarcinomas (GIACs). Hypermutated tumors were distinct regardless of cancer type and comprised those enriched for insertions/deletions, representing microsatellite instability cases with epigenetic silencing of MLH1 in the context of CpG island methylator phenotype, plus tumors with elevated single-nucleotide variants associated with mutations in POLE. Tumors with chromosomal instability were diverse, with gastroesophageal adenocarcinomas harboring fragmented genomes associated with genomic doubling and distinct mutational signatures. We identified a group of tumors in the colon and rectum lacking hypermutation and aneuploidy termed genome stable and enriched in DNA hypermethylation and mutations in KRAS, SOX9, and PCBP1.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cancer; colon; colorectal; epigenetic; esophagus; genomic; methylation; rectum; stomach; tumor

Mesh:

Substances:

Year:  2018        PMID: 29622466      PMCID: PMC5966039          DOI: 10.1016/j.ccell.2018.03.010

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  97 in total

1.  Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis.

Authors:  Amanda I Phipps; Michael N Passarelli; Andrew T Chan; Tabitha A Harrison; Jihyoun Jeon; Carolyn M Hutter; Sonja I Berndt; Hermann Brenner; Bette J Caan; Peter T Campbell; Jenny Chang-Claude; Stephen J Chanock; Jeremy P Cheadle; Keith R Curtis; David Duggan; David Fisher; Charles S Fuchs; Manish Gala; Edward L Giovannucci; Richard B Hayes; Michael Hoffmeister; Li Hsu; Eric J Jacobs; Lina Jansen; Richard Kaplan; Elisabeth J Kap; Timothy S Maughan; John D Potter; Robert E Schoen; Daniela Seminara; Martha L Slattery; Hannah West; Emily White; Ulrike Peters; Polly A Newcomb
Journal:  Carcinogenesis       Date:  2015-11-19       Impact factor: 4.944

2.  Integrated detection and population-genetic analysis of SNPs and copy number variation.

Authors:  Steven A McCarroll; Finny G Kuruvilla; Joshua M Korn; Simon Cawley; James Nemesh; Alec Wysoker; Michael H Shapero; Paul I W de Bakker; Julian B Maller; Andrew Kirby; Amanda L Elliott; Melissa Parkin; Earl Hubbell; Teresa Webster; Rui Mei; James Veitch; Patrick J Collins; Robert Handsaker; Steve Lincoln; Marcia Nizzari; John Blume; Keith W Jones; Rich Rava; Mark J Daly; Stacey B Gabriel; David Altshuler
Journal:  Nat Genet       Date:  2008-09-07       Impact factor: 38.330

3.  Krüppel-like factor 5 is important for maintenance of crypt architecture and barrier function in mouse intestine.

Authors:  Beth B McConnell; Samuel S Kim; Ke Yu; Amr M Ghaleb; Norifumi Takeda; Ichiro Manabe; Asma Nusrat; Ryozo Nagai; Vincent W Yang
Journal:  Gastroenterology       Date:  2011-07-18       Impact factor: 22.682

4.  Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial.

Authors:  Kei Muro; Hyun Cheol Chung; Veena Shankaran; Ravit Geva; Daniel Catenacci; Shilpa Gupta; Joseph Paul Eder; Talia Golan; Dung T Le; Barbara Burtness; Autumn J McRee; Chia-Chi Lin; Kumudu Pathiraja; Jared Lunceford; Kenneth Emancipator; Jonathan Juco; Minori Koshiji; Yung-Jue Bang
Journal:  Lancet Oncol       Date:  2016-05-03       Impact factor: 41.316

5.  Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy.

Authors:  Iain Beehuat Tan; Tatiana Ivanova; Kiat Hon Lim; Chee Wee Ong; Niantao Deng; Julian Lee; Sze Huey Tan; Jeanie Wu; Ming Hui Lee; Chia Huey Ooi; Sun Young Rha; Wai Keong Wong; Alex Boussioutas; Khay Guan Yeoh; Jimmy So; Wei Peng Yong; Akira Tsuburaya; Heike Grabsch; Han Chong Toh; Steven Rozen; Jae Ho Cheong; Sung Hoon Noh; Wei Kiat Wan; Jaffer A Ajani; Ju-Seog Lee; Manuel Salto Tellez; Patrick Tan
Journal:  Gastroenterology       Date:  2011-04-28       Impact factor: 22.682

6.  Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.

Authors:  J G Herman; A Umar; K Polyak; J R Graff; N Ahuja; J P Issa; S Markowitz; J K Willson; S R Hamilton; K W Kinzler; M F Kane; R D Kolodner; B Vogelstein; T A Kunkel; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

7.  Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.

Authors:  Katherine A Hoadley; Christina Yau; Denise M Wolf; Andrew D Cherniack; David Tamborero; Sam Ng; Max D M Leiserson; Beifang Niu; Michael D McLellan; Vladislav Uzunangelov; Jiashan Zhang; Cyriac Kandoth; Rehan Akbani; Hui Shen; Larsson Omberg; Andy Chu; Adam A Margolin; Laura J Van't Veer; Nuria Lopez-Bigas; Peter W Laird; Benjamin J Raphael; Li Ding; A Gordon Robertson; Lauren A Byers; Gordon B Mills; John N Weinstein; Carter Van Waes; Zhong Chen; Eric A Collisson; Christopher C Benz; Charles M Perou; Joshua M Stuart
Journal:  Cell       Date:  2014-08-07       Impact factor: 41.582

8.  Microsatellite and chromosomal stable colorectal cancers demonstrate poor immunogenicity and early disease recurrence.

Authors:  A Banerjea; R E Hands; M P Powar; S A Bustin; S Dorudi
Journal:  Colorectal Dis       Date:  2008-07-15       Impact factor: 3.788

9.  CDX2 is an amplified lineage-survival oncogene in colorectal cancer.

Authors:  Keyan Salari; Mary E Spulak; Justin Cuff; Andrew D Forster; Craig P Giacomini; Stephanie Huang; Melissa E Ko; Albert Y Lin; Matt van de Rijn; Jonathan R Pollack
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-29       Impact factor: 11.205

10.  Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.

Authors:  Austin M Dulak; Petar Stojanov; Shouyong Peng; Michael S Lawrence; Cameron Fox; Chip Stewart; Santhoshi Bandla; Yu Imamura; Steven E Schumacher; Erica Shefler; Aaron McKenna; Scott L Carter; Kristian Cibulskis; Andrey Sivachenko; Gordon Saksena; Douglas Voet; Alex H Ramos; Daniel Auclair; Kristin Thompson; Carrie Sougnez; Robert C Onofrio; Candace Guiducci; Rameen Beroukhim; Zhongren Zhou; Lin Lin; Jules Lin; Rishindra Reddy; Andrew Chang; Rodney Landrenau; Arjun Pennathur; Shuji Ogino; James D Luketich; Todd R Golub; Stacey B Gabriel; Eric S Lander; David G Beer; Tony E Godfrey; Gad Getz; Adam J Bass
Journal:  Nat Genet       Date:  2013-03-24       Impact factor: 38.330

View more
  155 in total

Review 1.  A systems approach to clinical oncology uses deep phenotyping to deliver personalized care.

Authors:  James T Yurkovich; Qiang Tian; Nathan D Price; Leroy Hood
Journal:  Nat Rev Clin Oncol       Date:  2019-10-16       Impact factor: 66.675

2.  NFE2L1 and NFE2L3 Complementarily Maintain Basal Proteasome Activity in Cancer Cells through CPEB3-Mediated Translational Repression.

Authors:  Tsuyoshi Waku; Hiroyuki Katayama; Miyako Hiraoka; Atsushi Hatanaka; Nanami Nakamura; Yuya Tanaka; Natsuko Tamura; Akira Watanabe; Akira Kobayashi
Journal:  Mol Cell Biol       Date:  2020-06-29       Impact factor: 4.272

3.  Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas.

Authors:  S Derks; L K de Klerk; X Xu; T Fleitas; K X Liu; Y Liu; F Dietlein; C Margolis; A M Chiaravalli; A C Da Silva; S Ogino; F G Akarca; G J Freeman; S J Rodig; J L Hornick; E van Allen; B Li; S X Liu; V Thorsson; A J Bass
Journal:  Ann Oncol       Date:  2020-05-06       Impact factor: 32.976

4.  Clinical-Grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning.

Authors:  Amelie Echle; Heike Irmgard Grabsch; Philip Quirke; Piet A van den Brandt; Nicholas P West; Gordon G A Hutchins; Lara R Heij; Xiuxiang Tan; Susan D Richman; Jeremias Krause; Elizabeth Alwers; Josien Jenniskens; Kelly Offermans; Richard Gray; Hermann Brenner; Jenny Chang-Claude; Christian Trautwein; Alexander T Pearson; Peter Boor; Tom Luedde; Nadine Therese Gaisa; Michael Hoffmeister; Jakob Nikolas Kather
Journal:  Gastroenterology       Date:  2020-06-17       Impact factor: 22.682

5.  EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer.

Authors:  Jorge A Carrasquillo; Maurizio Scaltriti; Nikolaus Schultz; Yelena Y Janjigian; Francisco Sanchez-Vega; Jaclyn F Hechtman; Pau Castel; Geoffrey Y Ku; Yaelle Tuvy; Helen Won; Christopher J Fong; Nancy Bouvier; Gouri J Nanjangud; Joanne Soong; Efsevia Vakiani; Mark Schattner; David P Kelsen; Robert A Lefkowitz; Karen Brown; Mario E Lacouture; Marinela Capanu; Marissa Mattar; Besnik Qeriqi; Fabiola Cecchi; Yuan Tian; Todd Hembrough; Rebecca J Nagy; Richard B Lanman; Steven M Larson; Neeta Pandit-Taskar; Heiko Schöder; Christine A Iacobuzio-Donahue; David H Ilson; Wolfgang A Weber; Michael F Berger; Elisa de Stanchina; Barry S Taylor; Jason S Lewis; David B Solit
Journal:  Cancer Discov       Date:  2018-11-21       Impact factor: 39.397

Review 6.  POLE proofreading defects: Contributions to mutagenesis and cancer.

Authors:  Vivian S Park; Zachary F Pursell
Journal:  DNA Repair (Amst)       Date:  2019-02-16

7.  Pan-cancer methylation analysis reveals an inverse correlation of tumor immunogenicity with methylation aberrancy.

Authors:  Changhee Park; Kyeonghun Jeong; Joon-Hyeong Park; Sohee Jung; Jeong Mo Bae; Kwangsoo Kim; Chan-Young Ock; Miso Kim; Bhumsuk Keam; Tae Min Kim; Yoon Kyung Jeon; Se-Hoon Lee; Ju-Seog Lee; Dong-Wan Kim; Gyeong Hoon Kang; Doo Hyun Chung; Dae Seog Heo
Journal:  Cancer Immunol Immunother       Date:  2020-11-24       Impact factor: 6.968

Review 8.  Genomics and Targeted Therapies in Gastroesophageal Adenocarcinoma.

Authors:  Ankur K Nagaraja; Osamu Kikuchi; Adam J Bass
Journal:  Cancer Discov       Date:  2019-11-14       Impact factor: 39.397

9.  Natural killer cell and stroma abundance are independently prognostic and predict gastric cancer chemotherapy benefit.

Authors:  Bailiang Li; Yuming Jiang; Guoxin Li; George A Fisher; Ruijiang Li
Journal:  JCI Insight       Date:  2020-05-07

10.  Molecular subtype switching in early-stage gastric cancers with multiple occurrences.

Authors:  Shinya Takaoka; Yosuke Hirotsu; Hiroshi Ohyama; Hitoshi Mochizuki; Kenji Amemiya; Toshio Oyama; Hiroshi Ashizawa; Dai Yoshimura; Keiko Nakagomi; Kenji Hosoda; Yoji Suzuki; Yuichiro Kojima; Masao Omata
Journal:  J Gastroenterol       Date:  2019-01-21       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.